Search

everythinglearnresearchcommunity

for

Search:↓

MK-R7 supplement with Cistanche Tubulosa and Laminaria Japonica extracts improved hair density and scalp health without adverse effects.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

A man developed an allergic skin reaction from a therapy cap used for hair loss treatment.

Computer-aided imaging system helps measure balding area in female pattern hair loss.

Trichoscopy is a useful tool for diagnosing hair and scalp diseases without needing skin biopsies.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Proteoglycans, especially in Nourkrin®, can effectively and safely treat hair loss.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Assessing newborn scalp hair can reveal important health information.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Melatonin may protect ear cells from damage caused by nicotine.

The hot-wire hair removal device is no better than shaving.

The symptoms described align more with Haberland syndrome, not Delleman-Oorthuys syndrome.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.